The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia

NCT05532800 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

255

Enrollment

OTHER

Sponsor class

Conditions

Hyperlipemia

Interventions

DRUG: JS002
DRUG: Placebo

Sponsor

Shanghai Junshi Bioscience Co., Ltd.